Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafamidis Phase 3 Trial in Cardiovascular Disease (Japan)
jRCT2080223130Phase 3Completed
- Start
- Mar 2016
- Modality
- Small Molecules
01
Overview
Phase 3 trial of tafamidis in amyloidotic transthyretin cardiomyopathy (ATTR-CM) (2 arms). Started Mar 2016; status: completed.
02
Drugs
tafamidis
03
Conditions
amyloidotic transthyretin cardiomyopathy (ATTR-CM)
Beyond the preview
Go deeper on jRCT2080223130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223130.